Yes it’s a big pie controlled by two companies , edwards revenue is 80% of what AVR is in , so gives u a idea when revenue flows into a biotech what it means to the company value , so ask yourself what is the revenue potential for AVR , I believe the market size will be bigger with duraVR , why can’t it be given to 65 year olds ? This what makes this attractive , anyway let’s wait for trials next year or so , more positive data means only one thing , higher takeover price
Keep in mind both Medtronic and Edward bought into this market by taking over companies same status as AVR for billion plus dollars , anyone wish to confirm here.
U would think $3b plus is achievable if these results are replicated in the fda and ec trials ,why wouldn’t they? Just had 13 people (and some very sick) show results which mimics a potential cure.
- Forums
- ASX - By Stock
- AVR
- Ann: Update on First In Human DurAVR THV Study
Ann: Update on First In Human DurAVR THV Study, page-15
-
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.50 |
Change
0.100(0.65%) |
Mkt cap ! $327.6M |
Open | High | Low | Value | Volume |
$15.15 | $15.50 | $15.00 | $108.6K | 7.185K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 341 | $15.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.50 | 371 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 341 | 15.000 |
1 | 1000 | 14.990 |
1 | 1000 | 14.900 |
1 | 1000 | 14.850 |
2 | 262 | 14.800 |
Price($) | Vol. | No. |
---|---|---|
15.500 | 371 | 1 |
15.660 | 1925 | 2 |
15.850 | 554 | 1 |
15.950 | 848 | 2 |
16.030 | 999 | 1 |
Last trade - 16.10pm 22/08/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online